(BDO) and Merck (known as MSD outside the United States and Canada), are working together to improve Black American participation in clinical trials.

Increasing involvement in clinical trials by Black Americans is paramount to improving the quality of healthcare now and for future generations. Merck was the first to sign on to list its trials on BDO’s Clinical Trials Resource Center (CTRC).

The CTRC is an online repository of information regarding clinical trials specifically targeting Black consumers. The historic partnership with BDO is designed to increase awareness, educate and help more Blacks get enrolled in clinical trials.

“We’re focused on how we can inform and encourage underrepresented communities to participate in clinical trials,” said Adrelia Allen, Executive Director, Clinical Trial Patient Diversity at Merck.

“Merck is a visionary organization and has shown great leadership in the industry by moving first on this opportunity to make more of their Clinical Trials available to Black patients,” said BDO CEO, Reggie Ware. “What we are doing has never been done before. There is now a comfortable, trusting place for Black people to get the important timely information they need to make informed decisions about Clinical Trials. Our goal is to normalize clinical trials.”

Jade Curtis, BDO Executive Editor added, “Companies like Merck allow BDO to fulfill our promise and mission. This mission requires strategic partners who are visionary, truly committed to health equity and ready to ensure that everyone who needs their medicines can have access to them regardless of race, creed or color.”

For more information, visit:

Leave a comment

Your email address will not be published. Required fields are marked *